Highlights in Myelofibrosis Research at ASH 2024: Comparing Momelotinib, Other JAK Inhibitors
13:31
Experts Talk Current and Emerging Therapies for Myelofibrosis
4:56
Highlights in Myelofibrosis Research at ASH 2024: Momelotinib in Anemic Patients
57:56
ASH 2024 Lymphoma and CLL Highlights
9:47
New Frontiers in Myelofibrosis Care Presented at ASH 2024
15:12
Breaking Ground in MDS: Noteworthy Developments in 2024
16:45
The Best of BELA Asks: Challenges Facing Senior E&C Leaders
7:36
Highlights in Myelofibrosis Research at ASH 2024: Experts’ Selections
18:48